ClinicalTrials.gov record
Terminated Phase 1 Interventional

Pharmacokinetics of Low Dose Ketamine Infusion

ClinicalTrials.gov ID: NCT00618397

Public ClinicalTrials.gov record NCT00618397. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I Trial to Determine Steady State Pharmacokinetics and Sedative Effects of Low Dose Ketamine Infusion

Study identification

NCT ID
NCT00618397
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1
Lead sponsor
University of Texas Southwestern Medical Center
Other
Enrollment
5 participants

Conditions and interventions

Interventions

  • Ketamine Drug

Drug

Eligibility (public fields only)

Age range
3 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
May 31, 2015
Completion
May 31, 2015
Last update posted
Oct 25, 2016

2006 – 2015

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Children's Medical Center Dallas, University of Texas Southwestern Dallas Texas 75235

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00618397, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 25, 2016 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00618397 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →